‘The End In Mind’ conference answers questions about psychedelics for end-of-life patients.
Read morePsychedelics Going Mainstream
The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary.
Read moreAre Doctors Ready for Psychedelics?
Psychedelic treatments are here, but doctors aren’t prepared.
So says Rick Doblin, founder and executive director of the Multidisciplinary Assn. for Psychedelic Studies.
Read moreWhy Do We Try to Change Our Consciusness?
Here is an interview with author Michael Pollan, discussing psychedelics and the human desire to change our consciousness.
Read moreResearch on Psilocybin and DMT
Contemplating a psychedelic “trip”?
Here is all you need to know about two of your options: Psilocybin vs. DMT.
Read morePodcast on Psychedelics
How Psychedelic Drugs Are Making a Comeback to Treat Depression
The hallucinogenic compound psilocybin is undergoing a renaissance-not as a recreational drug but as a potential treatment for mental health conditions. This podcast follows the journey of one participant of a scientific study into the psychedelic drug's effect on depression.
Read moreWearable Psychedelics?
Wearable psychedelics could soon give users maximum control over their trip.
Scientists are working on a pharmaceutical device to help give people the best possible experiences on the likes of DMT and LSD.
Read moreLatest Research on Psychedelics and Depression
Here’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read moreMushrooms in Space
In a new “astromycological” venture launched in conjunction with NASA, mycologist Paul Stamets and various research teams are studying how fungi can be leveraged to build extraterrestrial habitats and perhaps someday even terraform planets.
Read moreReframing a Bad Trip
This study shows that many psychedelic users turn to storytelling to reframe challenging trips into positive experiences.
Read morePsychedelics in Psychiatry
Recently, psychedelic drugs have once again taken popular culture by storm.
From the psychedelic startup companies newly forming on Wall Street to a recent New York Timesarticle that claims "psychedelic drugs are closer to medicinal use," it seems that there is a renewed media and medical interest in acid (LSD), mushrooms (psilocybin), ecstasy (MDMA), ayahuasca, DMT (dimethyltryptamine), and ketamine.
Read more